Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancers.
作者:
Alumkal(Joshi J),Herman(James G)
状态:
发布时间2012-11-13
, 更新时间 2016-11-25
期刊:
Cancer Discov
摘要:
This issue of Cancer Discovery features an article that describes distinct epigenetic mechanisms that operate in TMPRSS2-ERG fusion-negative prostate cancers. This finding clarifies molecular features of these TMPRSS2-ERG fusion-negative tumors and may have implications for how to treat this prostate cancer subtype.